Other examples include the recently reported ability of nuclear IGF-1R to drive chemotherapy resistance in various types of cancer, and notably, through interactions with nuclear mitotic apparatus (NuMA) protein and regulating p53−binding protein 1 (53BP1) −dependent DNA double−strand break repair in colorectal cancer (40). The gene discussed is IGF1R; the disease is colorectal cancer.